Premium
Increased bone resorption and osteopenia in Dlx5 heterozygous mice
Author(s) -
Samee Nadeem,
Geoffroy Valérie,
Marty Caroline,
Schiltz Corinne,
VieuxRochas Maxence,
ClémentLacroix Philippe,
Belleville Cécile,
Levi Giovanni,
de Vernejoul MarieChristine
Publication year - 2009
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.22188
Subject(s) - dlx5 , bone resorption , endocrinology , medicine , cortical bone , bone remodeling , resorption , osteopenia , osteoclast , osteoblast , deoxypyridinoline , bone mineral , osteoporosis , anatomy , biology , osteocalcin , gene expression , homeobox , receptor , gene , biochemistry , alkaline phosphatase , in vitro , enzyme
Distal‐less (Dlx) homeobox transcription factors play a central role in the control of osteogenesis. In particular, Dlx5 regulates osteoblasts/osteoclasts coupling during perinatal bone formation. We analyze here the effect of Dlx5 allelic reduction in the control of bone remodeling. We first show that Dlx5 expression persists during postnatal bone development. We then compare the skeletal phenotype of 10‐ and 20‐week‐old Dlx5 +/− mice to that of wild‐type (WT) littermates. Dlx5 +/− male mice exhibit lower bone mineral density (BMD) at both ages while only 20‐week‐old females are affected. µCT analyses reveal a reduction in cortical thickness of femoral midshafts in Dlx5 +/− mice. Histomorphometry on distal femora shows no changes in trabecular structure and confirms a reduction in Dlx5 +/− cortical thickness. The cortical decrease of 10‐week‐old mice does not derive from a reduction in periosteal bone apposition, but results from increased bone resorption with a significantly higher number of endosteal osteoclasts per bone surface and a larger marrow diameter. Urinary level of deoxypyridinoline is also higher in heterozygous mice confirming an increase in bone resorption activity. Our findings might be relevant for understanding complex, multifactorial diseases such as osteoporosis in which quantitative deregulation of gene expression leads to disruption of bone homeostasis. J. Cell. Biochem. 107: 865–872, 2009. © 2009 Wiley‐Liss, Inc.